Medindia

Improved Outcomes for Patients Treated with Lantus® and Apidra® Regimen Compared with Sliding Scale Insulin

PARIS, June 25 Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that results from the RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 ...
Medscape

Ask the Expert on . . . Lantus Conversion

Would you please explain how to convert 70/30 insulin coverage to Lantus coverage? When our patients are admitted to the hospital, they are usually converted to Lantus with a sliding scale. Patient AB ...
FierceBiotech

FDA Approves Apidra(R) SoloSTAR(R) - a Prefilled Disposable Insulin Pen

BRIDGEWATER, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) SoloSTAR(R ...
Business Wire

GoodRx Announces New Way for Consumers to Access Sanofi’s Lantus for $35 at Over 70,000 Pharmacies Nationwide

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced it is working with Sanofi (NASDAQ: SNY), a global leader in ...
Nasdaq

GoodRx Announces New Way for Consumers to Access Sanofi’s Lantus for $35 at Over 70,000 Pharmacies Nationwide

Integration allows people living with diabetes – with or without insurance – to access Sanofi’s most-prescribed insulin at a fixed rate anywhere GoodRx is accepted Through its Pharma Manufacturer ...